Related Experiment Video
Updated: Jul 24, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Long non‑coding RNA PTCSC3 suppresses triple‑negative breast cancer by downregulating long non‑coding RNA MIR100HG
Guojun Zhang1, Lei Gao1, Junliang Zhang1
1Department of General Surgery, Changle People's Hospital, Changle County, Shandong 262499, P.R. China.
Abstract:
Long non-coding RNA (lncRNA) PTCSC3 is characterized as a tumor suppressor in thyroid cancer and glioma. The present study aimed to investigate the role of PTCSC3 in triple-negative breast cancer (TNBC). A total of 82 patients with TNBC were enrolled in the present study. The results showed that PTCSC3 was downregulated, while lncRNA MIR100HG was upregulated in tumor tissues compared with that in adjacent non-cancerous tissues of patients with TNBC. The follow-up study showed that low expression levels of PTCSC3 and high expression levels of MIR100HG were closely associated with poor survival of patients with TNBC. The expression levels of MIR100HG were decreased with the clinic stages of TNBC, while the expression levels of MIR100HG showed the opposite trend. Correlation analysis showed that the expression levels of PTCSC3 and MIR100HG were significantly correlated in both tumor tissues and adjacent non-cancerous tissues. The overexpression of PTCSC3 inhibited the expression level of MIR100HG in TNBC cells, while the expression level of PTCSC3 was unaffected. Cell Counting Kit-8 and Annexin V-FITC Apoptosis flow cytometry assays showed that overexpression of PTCSC3 led to inhibition, while overexpression of MIR100HG led to the promotion of TNBC cells viability and inhibited apoptosis of TNBC cells. In addition, overexpression of MIR100HG attenuated the effects of PTCSC3 overexpression on cancer cell viability. However, the overexpression of PTCSC3 did not affect cancer cell migration and invasion. Western-blot analysis showed that PTCSC3 suppressed viability and promoted apoptosis of TNBC cells through the Hippo signaling pathway. Thus, the present study demonstrated that lncRNA PTCSC3 inhibits cancer cell viability and promotes cancer cell apoptosis in TNBC by downregulating MIR100HG.
Insights
Long non-coding RNA (lncRNA) PTCSC3 acts as a tumor suppressor in triple-negative breast cancer (TNBC). It inhibits cancer cell viability and promotes apoptosis by downregulating MIR100HG, impacting patient survival.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNA (lncRNA) PTCSC3 is a known tumor suppressor in thyroid cancer and glioma.
- Its role in triple-negative breast cancer (TNBC) remains largely unexplored.
Purpose of the Study:
- To investigate the function and molecular mechanisms of PTCSC3 in triple-negative breast cancer (TNBC).
- To explore the relationship between PTCSC3, MIR100HG, and TNBC progression.
Main Methods:
- Analysis of PTCSC3 and MIR100HG expression in 82 TNBC patient tissues.
- Cell viability (CCK-8) and apoptosis (Annexin V-FITC) assays.
- Western blot analysis to investigate signaling pathways (Hippo pathway).
Main Results:
- PTCSC3 was downregulated, and MIR100HG was upregulated in TNBC tissues.
- Low PTCSC3 and high MIR100HG expression correlated with poor patient survival.
- PTCSC3 overexpression inhibited MIR100HG, suppressed TNBC cell viability, and promoted apoptosis via the Hippo pathway.
- MIR100HG overexpression promoted TNBC cell viability and inhibited apoptosis, counteracting PTCSC3 effects.
Conclusions:
- lncRNA PTCSC3 functions as a tumor suppressor in TNBC by downregulating MIR100HG.
- PTCSC3 inhibits TNBC cell viability and promotes apoptosis, potentially through the Hippo signaling pathway.
- PTCSC3 and MIR100HG are significant prognostic biomarkers for TNBC patients.
Related Concept Videos
MicroRNAs
lncRNA - Long Non-coding RNAs
Experimental RNAi
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...

